Activities of daily life, education, and employment were areas of difficulty in the transition to adulthood for patients with ...

Having found that in biomedical research, the Bird Rock resident and scientist at La Jolla’s Sanford Burnham Prebys has ...

Muscular Dystrophy Association Clinical & Scientific Conference, convening in Dallas, Texas, from March 16-18, will feature ...

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), with a group of more than 150 advocates, will head to Capitol Hill ...

Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that the company will present data on sevasemten, an investigational orally ...

Columnist Patrick Moeschen offers a retrospective of what he did and didn't know about living with muscular dystrophy over four decades.

Older age, presence of scoliosis, and other factors were associated with lower predicted forced vital capacity in patients with Duchenne muscular dystrophy using non-invasive ventilation.

Researchers, physicians, families and affected patients view Duchenne muscular dystrophy (DMD) as a neuromuscular condition. Children are diagnosed during the first years of life because they have ...

Italfarmaco S.p.A. today announced a comprehensive update on the regulatory and clinical advancements for givinostat, the company’s drug for the treat ...

"Our community has secured critical policy victories that are transforming the lives of those affected by Duchenne and Becker muscular dystrophy. These achievements are the result of the efforts ...

The skeletal phenotype in Becker muscular dystrophy: The under-studied cousin of Duchenne Title: P19: Myosin inhibitor EDG-4131 improves pathophysiology and molecular pathology in BMD model mice ...